October 26, 2012
CHI and Cancer Commons will present a plenary panel on Personalized Oncology at the Molecular Medicine Tri-Conference, February 11 – 14, 2013, at Moscone North Convention Center, San Francisco.
The plenary, “Personalized Oncology – Fulfilling the Promise for Today’s Patients”, will be on Wednesday, February 13, from 8 am – 9:40 am.
For additional information regarding the plenary, see the conference preview.
For more details, see the Cancer Commons website.
April 20, 2012
Allan Schiffman, Executive Director of CommerceNet, will speak at the Asilomar Microcomputer Workshop on Wednesday evening, April 25. His talk is titled “How to Second-Guess Your Oncologist”.
The annual Asilomar Microcomputer Workshop brings together the movers, shakers, and greybeards of the industry. Since 1975 this workshop has been a small, informal, highly interactive forum, emphasizing works in progress and interesting problems rather than commercial products. It brings participants up to date on recent advances in the computer and technology fields, anticipates future trends, and provides a fun and mentally invigorating three days.
February 23, 2012
Dr. Tenenbaum was a Speaker and Chairperson at Molecular Med Tri-Con’s 2012, Inagural Bioinformatics and Cancerinformatics Session on February 23, 2012, entitled: “Translating Biomarker Driven Cancer Treatments into Practice” at the Moscone Convention Center in San Francisco, CA. Dr. Tenenbaum’s session was entitled: “Cancer Commons – A Rapid Learning Community for Cancer”.
Molecular Med Tri-Con 2012
October 16, 2011
Dr. Marty Tenenbaum, Chairman and co-Founder of CollabRx recently spoke at the Open Science Summit 2011 about Open Medicine and Clinical Trials 2.0. Dr. Tenenbaum described the concept of an open community that compiles and continually refines information about cancer subtypes and treatments based on actual patient outcomes.
September 28, 2011
CollabRx Chairman Marty Tenenbaum will chair a panel session entitled “Let’s Look at Cancer: What’s Happening in Personalized Medicine” at the 7th Annual Burrill & Company Personalized Medicine Meeting in October.
View the Burrill Personalized Medicine Meeting Agenda.
December 15, 2010
FasterCures, the Washington, DC-based center of the Milken Institute, convened the second annual Partnering for Cures meeting on December 14-15, 2010 in New York City.
This effort brings together medical research leaders and decision-makers, innovators, and advocates from across sectors to find workable solutions that will expedite the medical research and development process.
Dr. Tenenbaum gave an “Innovators Presentation” on Cancer Commons, an open science initiative where physicians, scientists, and patients collaborate on individualizing treatments.
See the presentation.
December 14, 2010
Overview: Cancer Commons is an open science initiative where physicians, scientists, and patients collaborate on individualizing treatments.
Its goals are to:
1) give each patient the best possible outcome by personalizing therapy based on his or her tumor’s genomic subtype,
2) learn as much as possible from each patient’s response, and
3) rapidly disseminate what is learned.
Cancer Commons provides patient communities with personalized, actionable information that can save lives, while providing the life sciences industry with a game-changing infrastructure that will slash the time and cost of developing new drugs and diagnostics and getting them to patients.
View Complete Presentation
March 18, 2010
Personalized Medicine is the application of genomic data to ensure the delivery of the right treatments and preventive measures to the right patient at the right time, ushering in a new era of affordable healthcare delivered with laser precision. Personalized Medicine 3.0 is the third annual one-day conference focused on the perspectives of non-profit and corporate research, biotechnology, academic, and diagnostic leaders with concentration on how the evolving landscape is revolutionizing medical care. The conference will explore what happens “on the ground” when personalized medicine is put into practice, and what that means for caregivers and patients, as well as for the industries that develop products for personalized medicine. This year, we concentrate on the role of personalized medicine in optimizing cancer diagnostics and treatment.
Learn more and register
June 10, 2009
This conference will cover keys issues, challenges and best practices for Collaborative Innovation in BioMedicine including:
- How to Create and Manage Consortia for Success
- Data Contribution, Results Sharing and Enhancement Solutions
- IP Issues for Consortia-Generated Knowledge
- Moving from Pre-Competitive Collaboration Back into Competitive Programs
- Case Studies of Leading Consortia
CommerceNet’s own Dr. Jay M. Tenenbaum will give the luncheon keynote on June 23 at 12:30 pm.
Learn more and register
May 6, 2009
Collaborating for Cures will bring together for the first time non-profit and industry leaders specifically focused on accelerating treatments and cures for brain and nervous system illnesses to promote the exchange of ideas, discuss funding opportunities and collaborative strategies.
Panelists and attendees will explore how new collaboration, innovative funding models, web-based collaborative infrastructures, and new partnership models are accelerating the development of treatments and cures for brain and nervous system illnesses.
CommerceNet’s own Dr. Jay M. Tenenbaum will give the keynote on May 11 from 8:30 – 9:00am and will also participate in the subsequent panel “Collaborative Research Infrastructure” from 9:00-10:30am.
Learn more and register